Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:epoxy fatty acid
go back to main search page
Accession:CHEBI:61498 term browser browse the term
Definition:A heterocyclic fatty acid containing an epoxide ring as part of its structure.
Synonyms:related_synonym: epoxy fatty acids;   epoxy-FA;   epoxy-FAs;   fatty acid epoxide;   fatty acid epoxides
 xref: PMID:15145985


show annotations for term's descendants           Sort by:
 
14,15-EET term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ACE angiotensin I converting enzyme decreases activity ISO 14,15-epoxy-5,8,11-eicosatrienoic acid analog results in decreased activity of ACE protein CTD PMID:27428043 NCBI chr17:63,477,061...63,498,373
Ensembl chr17:63,477,061...63,498,380
JBrowse link
G ACE2 angiotensin I converting enzyme 2 multiple interactions ISO 14,15-epoxy-5,8,11-eicosatrienoic acid analog promotes the reaction [REN2 protein results in increased expression of ACE2 protein] CTD PMID:27428043 NCBI chr  X:15,518,197...15,602,158
Ensembl chr  X:15,561,033...15,602,148
JBrowse link
G AGT angiotensinogen multiple interactions
decreases expression
increases cleavage
ISO 14,15-epoxy-5,8,11-eicosatrienoic acid analog inhibits the reaction [REN2 protein results in increased expression of AGT protein modified form]
14,15-epoxy-5,8,11-eicosatrienoic acid analog results in decreased expression of AGT protein modified form
[14,15-epoxy-5,8,11-eicosatrienoic acid analog results in increased cleavage of AGT protein modified form] which results in increased abundance of angiotensin I (1-7)
CTD PMID:27428043 NCBI chr 1:230,702,523...230,745,583
Ensembl chr 1:230,702,523...230,714,122
JBrowse link
G AKT1 AKT serine/threonine kinase 1 increases phosphorylation EXP 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of AKT1 protein CTD PMID:16286479 NCBI chr14:104,769,349...104,795,748
Ensembl chr14:104,769,349...104,795,751
JBrowse link
G CYP2C8 cytochrome P450 family 2 subfamily C member 8 increases chemical synthesis EXP CYP2C8 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid CTD PMID:12675279 NCBI chr10:95,036,772...95,069,497
Ensembl chr10:95,036,772...95,069,497
JBrowse link
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 increases chemical synthesis
multiple interactions
EXP CYP2C9 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid
Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid]
CTD PMID:12675279 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases chemical synthesis
multiple interactions
EXP CYP3A4 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid
Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 14,15-epoxy-5,8,11-eicosatrienoic acid]
CTD PMID:12675279 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G EPHX2 epoxide hydrolase 2 multiple interactions
increases abundance
ISO [Arsenites results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid; [Mercuric Chloride results in increased expression of and results in increased activity of EPHX2 protein] which results in decreased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid
EPHX2 gene mutant form results in increased abundance of 14,15-epoxy-5,8,11-eicosatrienoic acid
CTD PMID:19896470, PMID:22680237, PMID:24472606 NCBI chr 8:27,491,143...27,597,559
Ensembl chr 8:27,490,781...27,545,564
JBrowse link
G FGF2 fibroblast growth factor 2 increases expression EXP 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased expression of FGF2 protein CTD PMID:16286479 NCBI chr 4:122,826,708...122,898,236
Ensembl chr 4:122,826,708...122,898,236
JBrowse link
G MAPK1 mitogen-activated protein kinase 1 increases phosphorylation ISO 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of MAPK1 protein CTD PMID:19464254 NCBI chr22:21,759,657...21,867,680
Ensembl chr22:21,754,500...21,867,680
Ensembl chr22:21,754,500...21,867,680
JBrowse link
G MAPK3 mitogen-activated protein kinase 3 increases phosphorylation ISO 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of MAPK3 protein CTD PMID:19464254 NCBI chr16:30,114,105...30,123,309
Ensembl chr16:30,114,105...30,123,506
JBrowse link
G RPS6KB1 ribosomal protein S6 kinase B1 increases phosphorylation EXP 14,15-epoxy-5,8,11-eicosatrienoic acid results in increased phosphorylation of RPS6KB1 protein CTD PMID:16286479 NCBI chr17:59,893,121...59,950,574
Ensembl chr17:59,893,046...59,950,574
JBrowse link
G TGFB1 transforming growth factor beta 1 multiple interactions
decreases secretion
EXP 12-(3-adamantan-1-ylureido)dodecanoic acid inhibits the reaction [TGFB1 protein results in decreased secretion of 14,15-epoxy-5,8,11-eicosatrienoic acid] CTD PMID:28694203 NCBI chr19:41,330,323...41,353,922
Ensembl chr19:41,301,587...41,353,922
JBrowse link
5,6-EET term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 multiple interactions
increases chemical synthesis
EXP Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 5,6-epoxy-8,11,14-eicosatrienoic acid] CTD PMID:12675279 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G EPHX2 epoxide hydrolase 2 increases abundance ISO EPHX2 gene mutant form results in increased abundance of 5,6-epoxy-8,11,14-eicosatrienoic acid CTD PMID:19896470 NCBI chr 8:27,491,143...27,597,559
Ensembl chr 8:27,490,781...27,545,564
JBrowse link
8,9-EET term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G CYP2C9 cytochrome P450 family 2 subfamily C member 9 increases chemical synthesis
multiple interactions
EXP CYP2C9 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid
Sulfaphenazole inhibits the reaction [CYP2C9 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid]
CTD PMID:12675279 NCBI chr10:94,938,658...94,990,091
Ensembl chr10:94,938,658...94,990,091
JBrowse link
G CYP3A4 cytochrome P450 family 3 subfamily A member 4 increases chemical synthesis
multiple interactions
EXP CYP3A4 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid
Ketoconazole inhibits the reaction [CYP3A4 protein results in increased chemical synthesis of 8,9-epoxyeicosatrienoic acid]
CTD PMID:12675279 NCBI chr 7:99,756,967...99,784,184
Ensembl chr 7:99,756,960...99,784,248
JBrowse link
G EPHX1 epoxide hydrolase 1 affects hydrolysis ISO EPHX1 protein affects the hydrolysis of 8,9-epoxyeicosatrienoic acid CTD PMID:28975360 NCBI chr 1:225,810,124...225,845,563
Ensembl chr 1:225,810,092...225,845,563
JBrowse link
G EPHX2 epoxide hydrolase 2 increases abundance ISO EPHX2 gene mutant form results in increased abundance of 8,9-epoxyeicosatrienoic acid CTD PMID:19896470 NCBI chr 8:27,491,143...27,597,559
Ensembl chr 8:27,490,781...27,545,564
JBrowse link
leukotriene A4 term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G ALOX5 arachidonate 5-lipoxygenase increases chemical synthesis EXP ALOX5 protein results in increased chemical synthesis of Leukotriene A4 CTD PMID:18295198 NCBI chr10:45,374,209...45,446,121
Ensembl chr10:45,374,176...45,446,119
JBrowse link
G LTA4H leukotriene A4 hydrolase multiple interactions
increases hydrolysis
EXP cyclohexene inhibits the reaction [LTA4H protein results in increased hydrolysis of Leukotriene A4]; Oxygen inhibits the reaction [LTA4H protein results in increased hydrolysis of Leukotriene A4]; Piperonyl Butoxide inhibits the reaction [LTA4H protein results in increased hydrolysis of Leukotriene A4]; propanethiol inhibits the reaction [LTA4H protein results in increased hydrolysis of Leukotriene A4] CTD PMID:2827578 NCBI chr12:96,000,753...96,043,520
Ensembl chr12:96,000,753...96,043,520
JBrowse link
G MGST1 microsomal glutathione S-transferase 1 decreases activity ISO Leukotriene A4 results in decreased activity of MGST1 protein CTD PMID:9890956 NCBI chr12:16,347,115...16,377,192
Ensembl chr12:16,347,142...16,609,259
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 24359
    chemical entity 24327
      molecular entity 24285
        main group molecular entity 24160
          gas molecular entity 19319
            oxirane 5832
              epoxide 5830
                epoxy monocarboxylic acid 26
                  epoxy fatty acid 17
                    (13S)-12,13-epoxyoctadeca-9,11-dienoic acid + 0
                    (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid 0
                    (16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid 0
                    (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid 0
                    (4Z,9E,11E,13Z,15E,17S,19Z)-7,8-epoxy-17-hydroxydocosahexaenoic acid 0
                    (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid 0
                    (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid 0
                    (9S),10-epoxy-(10,12Z)-octadecadienoic acid 0
                    (9Z,11Z,13S,15Z)-12,13-epoxyoctadecatrienoic acid 0
                    (9Z,13S,15Z)-12,13-epoxyoctadeca-9,11,15-trienoic acid 0
                    11(S)-hydroxy-14(S),15(S)-hepoxilin A3 0
                    11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoic acid 0
                    12,13-epoxy-18-hydroxy-(9Z)-octadecenoic acid 0
                    14,15-EpETE 0
                    15(16)-EpODE 0
                    17R,(16)-epoxy-(4Z,7Z,10Z,13Z,19Z)-docosahexa-4,7,10,13,15,19-enoic acid 0
                    17S,(16)-epoxy-(4Z,7Z,10Z,13Z,19Z)-docosahexa-4,7,10,13,15,19-enoic acid 0
                    4,5-leukotriene A4 0
                    4S(5)-epoxy-17R-hydroxydocosahexaenoic acid 0
                    5(S),6(S)-epoxy-18(R)-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid 0
                    5(S),6(S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid + 0
                    5(S)6-epoxy-18(S)-HEPE 0
                    7,8-epoxy,17-hydroxy-(9E,11E,13Z,15E,19Z)-docosapentaenoic acid 0
                    7S,8S-epoxy-17R-hydroxydocosahexaenoic acid 0
                    9(10)-EpODE 0
                    9,10-epoxy-17-hydroxyoctadecanoic acid 0
                    9,10-epoxy-18-hydroxy-(12Z)-octadecenoic acid 0
                    9,10-epoxy-18-hydroxyoctadecanoic acid + 0
                    A-12(13)-EpODE 0
                    EET + 14
                    EpETE + 0
                    eoxin A4 0
                    epoxy(hydroxy)icosatrienoic acid + 0
                    epoxydocosapentaenoic acid + 0
                    epoxydocosatetraenoic acid + 0
                    epoxyoctadecenoic acid + 0
                    epoxystearic acid + 0
                    hepoxilin A3 + 0
                    hepoxilin B3 0
                    hydroperoxy(epoxy)icosatrienoic acid + 0
                    juvenile hormone I acid 0
                    juvenile hormone III acid 0
                    leukotriene A4 + 3
                    vernolic acid + 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 24359
    subatomic particle 24315
      composite particle 24315
        hadron 24315
          baryon 24315
            nucleon 24315
              atomic nucleus 24315
                atom 24315
                  main group element atom 24160
                    p-block element atom 24160
                      carbon group element atom 23936
                        carbon atom 23892
                          organic molecular entity 23892
                            organic group 22174
                              organic divalent group 22148
                                organodiyl group 22148
                                  carbonyl group 22127
                                    carbonyl compound 22127
                                      carboxylic acid 21157
                                        monocarboxylic acid 20034
                                          fatty acid 18200
                                            cyclic fatty acid 517
                                              heterocyclic fatty acid 192
                                                epoxy fatty acid 17
                                                  (13S)-12,13-epoxyoctadeca-9,11-dienoic acid + 0
                                                  (13S,14S)-epoxy-(4Z,7Z,9E,11E,16Z,19Z)-docosahexaenoic acid 0
                                                  (16S,17S)-epoxy-(4Z,7Z,10Z,12E,14E,19Z)-docosahexaenoic acid 0
                                                  (2E,6E,10R,11S)-10,11-epoxy-3,7,11-trimethyltrideca-2,6-dienoic acid 0
                                                  (4Z,9E,11E,13Z,15E,17S,19Z)-7,8-epoxy-17-hydroxydocosahexaenoic acid 0
                                                  (5Z,9E,14Z)-(8xi,11R,12S)-11,12-epoxy-8-hydroxyicosa-5,9,14-trienoic acid 0
                                                  (7R)-hydroxy-(5S,6S)-epoxy-(8Z,11Z,14Z)-icosatrienoic acid 0
                                                  (9S),10-epoxy-(10,12Z)-octadecadienoic acid 0
                                                  (9Z,11Z,13S,15Z)-12,13-epoxyoctadecatrienoic acid 0
                                                  (9Z,13S,15Z)-12,13-epoxyoctadeca-9,11,15-trienoic acid 0
                                                  11(S)-hydroxy-14(S),15(S)-hepoxilin A3 0
                                                  11-hydroxy-(12S,13S)-epoxy-(9Z)-octadecenoic acid 0
                                                  12,13-epoxy-18-hydroxy-(9Z)-octadecenoic acid 0
                                                  14,15-EpETE 0
                                                  15(16)-EpODE 0
                                                  17R,(16)-epoxy-(4Z,7Z,10Z,13Z,19Z)-docosahexa-4,7,10,13,15,19-enoic acid 0
                                                  17S,(16)-epoxy-(4Z,7Z,10Z,13Z,19Z)-docosahexa-4,7,10,13,15,19-enoic acid 0
                                                  4,5-leukotriene A4 0
                                                  4S(5)-epoxy-17R-hydroxydocosahexaenoic acid 0
                                                  5(S),6(S)-epoxy-18(R)-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid 0
                                                  5(S),6(S)-epoxy-18-hydroxy-(7E,9E,11Z,14Z,16E)-icosapentaenoic acid + 0
                                                  5(S)6-epoxy-18(S)-HEPE 0
                                                  7,8-epoxy,17-hydroxy-(9E,11E,13Z,15E,19Z)-docosapentaenoic acid 0
                                                  7S,8S-epoxy-17R-hydroxydocosahexaenoic acid 0
                                                  9(10)-EpODE 0
                                                  9,10-epoxy-17-hydroxyoctadecanoic acid 0
                                                  9,10-epoxy-18-hydroxy-(12Z)-octadecenoic acid 0
                                                  9,10-epoxy-18-hydroxyoctadecanoic acid + 0
                                                  A-12(13)-EpODE 0
                                                  EET + 14
                                                  EpETE + 0
                                                  eoxin A4 0
                                                  epoxy(hydroxy)icosatrienoic acid + 0
                                                  epoxydocosapentaenoic acid + 0
                                                  epoxydocosatetraenoic acid + 0
                                                  epoxyoctadecenoic acid + 0
                                                  epoxystearic acid + 0
                                                  hepoxilin A3 + 0
                                                  hepoxilin B3 0
                                                  hydroperoxy(epoxy)icosatrienoic acid + 0
                                                  juvenile hormone I acid 0
                                                  juvenile hormone III acid 0
                                                  leukotriene A4 + 3
                                                  vernolic acid + 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.